HYPE: Drinking clove tea controls blood sugar and reduces inflammation.
But what does the evidence actually show?
Clove compounds have plausible laboratory effects, but direct evidence for ordinary clove tea is weak. A small uncontrolled study of a standardised extract cannot establish that a home-brewed drink treats diabetes or inflammatory disease.
What is the hype?
Cloves contain eugenol and other compounds studied for biological activity. A warm spice drink can also be enjoyable. The scientific leap occurs when an experiment on a compound or concentrated extract becomes a promise about a variable cup of tea.
The human pilot was not a tea trial
A 2019 open-label study gave a water-soluble polyphenol-rich clove extract to 13 volunteers for 30 days. They were divided by starting glucose level rather than randomised against placebo. Selected pre-meal and post-meal glucose measurements decreased. This is an early signal worth testing, but without a control group it cannot exclude normal variation, changed behaviour or regression towards typical values. [1]
Why the preparation matters
The trial used 250 mg daily of a defined extract. That is a description of the research, not a recommendation or a tea recipe. Brewing time, the amount of cloves and the compounds extracted into water can change exposure. A home drink cannot be assumed to provide the tested preparation simply because both began with the same plant. [1]
Inflammatory pathways are not a clinical endpoint
The pilot also included cell and enzyme experiments relevant to glucose handling. LiverTox describes in-vitro biological activity of eugenol, but such effects do not establish relief of a person's inflammatory condition. A useful clinical trial would need a defined drink, an appropriate comparison and meaningful outcomes, rather than only an antioxidant or signalling assay. [1] [2]
Tea and concentrated oil need separate safety judgments
LiverTox distinguishes low exposures from large ingestions of clove oil, which can cause severe toxicity. It would be misleading to assign an overdose risk directly to a normal food-flavoured tea, and equally misleading to assume that concentrated oil is just a stronger drink. Preparation and exposure are central to both benefit and harm. [2]
The catch: limitations and uncertainty
The direct human evidence assessed is very small and unblinded, with no placebo group. Short-term glucose measurements do not establish durable HbA1c improvement, prevention of complications or a medication replacement. This targeted review did not identify a convincing controlled trial of ordinary clove tea for the advertised combined outcomes.
What this means for you
Enjoy clove tea as a beverage if it suits you, without expecting it to replace diabetes care. Do not drink essential oil or convert an extract-trial amount into a home-treatment dose. If you use glucose-lowering medicines or have persistent symptoms, discuss concentrated supplements with your clinician rather than adjusting treatment around an unverified tea claim.
A plausible spice story, with little direct proof for the cup being advertised.
Research & Sources
1. Water-soluble polyphenol-rich clove extract lowers pre- and post-prandial blood glucose levels in healthy and prediabetic volunteers: an open label pilot study (2019).
Published abstract; 13 participants, extract rather than tea.
Read the original source ↗2. NIH LiverTox. Eugenol (Clove Oil).
Clinical toxicology reference; concentrated oil differs from food exposure.
Read the original source ↗Evidence reviewed: October 2026
This targeted editorial review considered sources available in October 2026. It is not an exhaustive systematic review. Source access and indirect evidence are identified above. Evidence vs Hype provides education, not individual diagnosis or treatment. Original AI-generated featured artwork is conceptual and does not demonstrate a study result. No commercial product was selected or endorsed.